跳至主要内容
临床试验/JPRN-UMIN000039470
JPRN-UMIN000039470已完成未知

Two-group, parallel, double-blind study to evaluate the effects of limonite intake on glucose metabolism during 12 weeks. - Sugar metabolism test.

Mie University, Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) HbA1c value measured during the observation period exceeded 6.5 2) Persons who do not take iron preparations or supplements or drugs intended to take iron (meaning iron 10 mg / day or heme iron more than 100 mg/day) 3) A person who is judged by the doctor to have high blood pressure based on the blood pressure measured during the observation period. (If the measured value exceeds 200 mmHg at the time of visit, the doctor who interviews and judges three times.) 4) Patients who go to the hospital regularly and need to be treated with medicines such as oral medicines (Glucose tolerance and intestinal flora are not affected and transient ones are not excluded. Example: Cold, Transient dermatitis, etc.,Exclude hospital visits due to chronic illness with or without effects) 5) Patients who are judged by the investigator or investigator to be inappropriate as subjects

研究者

发起方
Mie University, Graduate School of Medicine

相似试验

进行中(未招募)
不适用
A randomised, double-blinded parallel group study to compare efficacy and tolerability of topically applied Baceca and Tazarotene against placebo and Tazarotene in patients with basal cell carcinoma - N/Askin cancer of the type of Basal Cell Carcinoma (BCC)
EUCTR2005-001474-27-DKTopoTarget A/S
进行中(未招募)
不适用
Efficacy and safety of Sarilumab and Adalimumab monotherapy in patients with Rheumatoid ArthritisRheumatoid Arthritis
EUCTR2014-002541-22-GBsanofi-aventis recherche & développement340
进行中(未招募)
1 期
Efficacy and safety of Sarilumab and Adalimumab monotherapy in patients with Rheumatoid ArthritisMedDRA version: 17.1 Level: PT Classification code 10039073 Term: Rheumatoid arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid Arthritis
EUCTR2014-002541-22-ESsanofi-aventis recherche & développement340
进行中(未招募)
1 期
Efficacy and safety of Sarilumab and Adalimumab monotherapy in patients with Rheumatoid ArthritisMedDRA version: 20.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid Arthritis
EUCTR2014-002541-22-DEsanofi-aventis recherche & développement540
进行中(未招募)
1 期
Efficacy and safety of Sarilumab and Adalimumab monotherapy in patients with Rheumatoid ArthritisMedDRA version: 17.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid Arthritis
EUCTR2014-002541-22-HUsanofi-aventis recherche & développement340